Trial · NCT02466386
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | SPD489 | 86 | Participants | ||
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Bedtime Resistance: Week 52/ET | 8.9 | Standard Deviation 3.04 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Sleep-onset Delay: Week 52/ET | 1.6 | Standard Deviation 0.67 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Sleep Duration: Week 52/ET | 3.8 | Standard Deviation 1.26 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Sleep Anxiety: Week 52/ET | 5.5 | Standard Deviation 2.09 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Night Wakings: Week 52/ET | 4.2 | Standard Deviation 1.59 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Parasomnias: Week 52/ET | 8.6 | Standard Deviation 1.54 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Sleep-disordered Breathing: Week 52/ET | 3.4 | Standard Deviation 0.74 | Score on scale |
| Change From Baseline in Sleep Patterns Assessed by Children's Sleep Habits Questionnaire (CSHQ) at Week 52/ Early Termination (ET) | SPD489 | Daytime Sleepiness: Week 52/ET | 10.1 | Standard Deviation 3.78 | Score on scale |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | Heart Rate (< 55 Beats per minute) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | Heart Rate (> 130 Beats per minute) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | PR Interval (>= 200 millisecond [msec]) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QRS Interval (>= 90 msec) | 3 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QT Interval (> = 440 msec) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcB Interval (> = 440 msec and < 480 msec) | 5 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcB Interval (>= 480 msec and < 500 msec) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcB Interval (>= 500 msec) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcF Interval (> = 440 msec and < 480 msec) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcF Interval (>= 480 msec and < 500 msec) | 0 | Participants | |
| Number of Participants With Potentially Clinically Significant Changes in Electrocardiogram (ECG) Parameters at Week 52/ Early Termination (ET) | SPD489 | QTcF Interval (>= 500 msec) | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02466386/results